Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons dr. B.P.C. (Bouke) Hazenberg

dr. B.P.C. (Bouke) Hazenberg

Oud Universitair Docent Geneeskunde, Reumatoloog niet praktiserend, voormalig hoofd van het Expertisecentrum Amyloïdose
Profielfoto van dr. B.P.C. (Bouke) Hazenberg
E-mail:
b.p.c.hazenberg rug.nl

Publicaties

Assessing Serum Neurofilament Light Chain in Hereditary Transthyretin Amyloidosis: Direct Comparison of Three Immunoassays

Exploratory Evaluation of the Predictive Value of Serum Neurofilament Light Chain for Autonomic Neuropathy in Hereditary Transthyretin Amyloidosis

Ongoing or halted amyloid deposition in systemic amyloidosis: essential to know early, but which tools may give early insight?

Pittsburgh compound B positron emission tomography detects cardiomyopathy in hereditary transthyretin amyloidosis patients with negative bone scintigraphy: a pilot study

Detecting early cardiomyopathy in transthyretin variant carriers: reappraising the diagnostic value of Perugini grade 1 radiotracer uptake on bone scintigraphy

Diagnostic performance of liver stiffness as marker of liver involvement in systemic immunoglobulin light chain (AL) amyloidosis

Multigene panel analysis has limited additional value compared to transthyretin gene analysis in Dutch patients with suspected cardiac amyloidosis

AA amyloidosis in a father and daughter as complication of PSTPIP1-associated myeloid-related proteinemia inflammatory (PAMI) syndrome

Cardiac [99mTc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker?: an early follow-up marker?

Circulating ECM proteins decorin and alpha-L-iduronidase differentiate ATTRwt-CM from ATTRwt-negative HFpEF/HFmrEF

Sustainable Development Goals

SDG 3 – Goede gezondheid en welzijnSDG 17 - Partnerschap om de doelen te bereiken

Meer informatie over de Sustainable Development Goals.